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Summary The protein and glycoprotein composition of Triton X-100 extracts of breast biopsies from 17
women with benign breast disease and from 11 women with invasive breast carcinoma were investigated using
electrophoresis in SDS-containing gradient polyacrylamide gels, followed by Coomassie Blue (CB) staining
and the binding of radio-iodinated wheat germ agglutinin (WGA). Patterns were analysed after the CB-step
for differences in protein composition, and after the WGA-step for differences in glycoprotein composition.
Tissue extracts from patients with benign breast disease have less CB stained bands than similar extracts from
the cancer patients. A particular consistent change was the appearance of an extra band at 58 Kdaltons in the
cancer extracts. In contrast to the CB results, WGA detected less major bands, in the 40-60Kd region, in the
cancer extracts than at similar locations in benign extracts. Analysis of blood sera using the above techniques
suggested that certain serum proteins could account for some of the WGA changes, but not the changes after
CB staining. However, residual contamination of the specimens by blood proteins seemed unlikely because of
the washing procedure used, unless these components were very strongly associated with the tissue.
Differential synthesis of serum proteins by benign and malignant breast tissue may also explain some of our
findings. Examination of the histopathology adjacent to the extracted tissue suggested that the degree of
reduction in WGA-binding may be related to the extent of local invasiveness. Other animal and human
studies suggest that reduced glycosylation of tumour-associated proteins may be linked to increased
malignancy. The current findings may reflect a general pattern of change in tumour glycoprotein composition
linked to malignant expression.
Frequently, it is very difficult to diagnose the severity of
breast cancer. In some cases, even when the cancer appears
to be of low malignancy and limited to the breast, the
disease may return many years later to kill the host. If
axillary lymph nodes are not examined, prognosis is
determined by histopathological criteria and these can often
be inaccurate. There is a need for additional tests to help the
clinician plan therapeutic strategy.
Evidence indicates that protein glycosylation can be
altered in cancer (Turner, 1982; Smets & Van Beek, 1984). In
a study of the role of surface glycoproteins in metastasis, we
have previously demonstrated that after cancer cells have
spread to a distant site, the content of wheat germ agglutinin
(WGA)-binding proteins associated with the cancer cell
membrane are considerably reduced (Chan et al., 1982). This
process was shown to occur for tumour systems that
metastasized to both the liver (Chan et al., 1984) and the
lungs (Turner & Chan, 1985). As this change could not be
detected by other lectins (Chan et al., 1985) this suggested to
us that the molecular species involved could be a fairly
distinct class of carbohydrate groupings on the protein
molecules. Similar components could also be altered in
human breast cancer. The present study was undertaken to
investigate this possibility, by determining the distribution of
WGA-binding proteins in extracts from benign and
malignant breast tumours, using electrophoresis and
autoradiography. The overall protein composition of the
extracts was also determined after electrophoresis, by
prestaining with Coomassie Blue (CB).
Materials and methods
Specimens for biochemical investigation were obtained from
pieces of breast tissue of 28 women who had undergone
either a lumpectomy or a mastectomy. Immediately after
removal of the tissue, the affected area was dissected away
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from the rest of the tissue by a pathologist and subdivided
into a piece for biochemistry and pieces for diagnostic
histopathology; one of the latter being cut with a face
adjacent to the piece used for biochemistry. Seventeen
women were later diagnosed as having cystic disease or
fibroadenoma of the breast (age range 29-49 years) and
eleven women were found to have an infiltrative ductal or
lobular breast carcinoma (age range 38-70 years). The
majority of the carcinomas were also graded (Bloom &
Richardson, 1957), and pieces of axillary tissue were
examined histologically for lymph node metastases. Axillary
lymph nodes were found only in 4/11 patients. Excess fat
was trimmed-off from the specimen used for biochemistry
and it was kept on dry-ice for transporting to the laboratory
before transferring to -70°C for long-term storage.
Tissue proteins were extracted as follows. The specimen
(1.8-0.2g) was allowed to thaw-out at 4°C in 20ml PBS 'A'
containing I mmol 1-1 phenyl methyl sulphonyl fluoride
(PMSF) and, when it was thawed out, it was shaken in three
changes of the same buffer to remove any superficial blood
contamination; although this was always very minor in all
specimens. The tissue was then minced-up very finely
(< I mm) with scissors in a small aliquot of the PBS
'A'/PMSF buffer in a large Petri dish. A 2ml aliquot of the
buffer was added to the pieces, they were transferred with a
wide-bore pasteur to a plastic universal and after making the
buffer up to 20ml the tissue was sedimented by
centrifugation at 600g for 3min. Further washes with 20ml
PBS/PMSF were carried out until the supernatant after
centrifugation was clear; this was always carried out at least
five times. The tissue sludge was suspended in 0.5 ml
Tris/HCI pH8.0 (10mmoll-) buffer containing 0.5% (v/v)
Triton X100 and 1mmoll- PMSF by vortexing for 1min.
Vortexing was repeated every 5min, with the suspension left
standing at 25°C for a total extraction time of - 30min.
Unsolubilized material was removed by centrifugation at
600g for 5min and the supernatant was stored at -70°C.
The extract was further subjected to centrifugation (12,000g
for 4min) prior to the estimation of the protein content by
the method of Bensadoun and Weinstein (1976).
According to Butters and Hughes (1974), the above
extraction procedure removes the majority of glycoproteins
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associated with cell membrane. This finding has been further
confirmed by the studies of Bramwell & Harris (1978) and
Chan et al. (1984) in which glycoproteins extracted by Triton
Xl 00 from various animal tumours were found to be
virtually identical to those extracted from corresponding
isolated membranes.
Whole blood (no anti-coagulant) was obtained from three
healthy women of a similar age to those providing the tissue
specimens. None of these women were taking oral
contraceptives or any other medication. Red blood cells were
removed by centrifugation and the sera were stored at
-20"C until required.
Tissue extracts and serum specimens were subjected to
slab gel electrophoresis, the gels fixed and stained with CB,
and the separated proteins treated with WGA as previously
described (Chan et al., 1984). Prior to electrophoresis, tissue
extracts were centrifuged at 12,000g for 4min and 120,ug
protein aliquots of the supernatant were diluted 1+2 with
Tris/HCl buffer, pH8.4 (10mmoll-1) containing 2% (w/v)
sodium dodecyl sulphate (SDS), 10% glycerol, 0.1 mmoll-1
dithiothreitol and 0.001% (w/v) bromophenol blue. When
serum was used for electrophoresis, 700,ug of protein were
diluted 1 +6 with the above loading buffer. The tissue
extract or serum mixture was immersed in a boiling water
bath for 2min and left to cool at room temperature.
Although the centrifugation procedure used to prepare the
tissue extracts would not have removed very small pieces of
subcellular membrane, the subsequent treatment with Triton
Patients a b c
X100 followed by boiling in SDS would have solubilized
most insoluble proteins.
An aliquot (5-70,l) containing 50jug protein was
separated by sodium dodecyl sulphate (SDS) gradient (7.5-
20%) polyacrylamide electrophoresis in slabs. The following
molecular weight markers were used to calibrate each
separation: RNA polymerase subunits 165 Kd, 155 Kd and
39Kd; bovine serum albumin, 68 Kd; and trypsin inhibitor
(TI), 21.5 Kd (Boehringer). After electrophoresis, the gels
were stained with CB R250 and destained in a solution
containing methanol/acetic acid/water. WGA was labelled
using a method previously described (Chan et al., 1984). The
fixed and stained gel was incubated overnight with the
100ml lectin solution (- 50 gml-1) at room temperature
with constant shaking. Unbound lectin was removed by
extensive washing (10 changes) for 2 days in 200ml
0.1 mol1- 1 phosphate buffer, pH =6.8, containing 0.4mol 1-1
sodium chloride. After WGA treatment, the gel was dried
down in dialysis membrane and the bound lectin visualized
by exposure to X-ray film. The CB-stained patterns were
assessed directly from the dried-down gels, either by visual
inspection or by scanning with a laser densitometer (LKB
Ltd.).
Results
Figures 1 and 2 show the CB-stained patterns obtained for
protein extracts from benign and malignant breast lumps.
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Figure 1 Electrophoretic analyses of protein extracts of breast tissue from women with benign breast disease. Protein bands were
stained with CB. In Figures 1-6, each patient is identified by a different letter; different electrophoretic runs are labelled with
Roman numerals; and the positions of the mol. wt markers are indicated by small arrows on the left of the separations.
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Figure 2 Electrophoretic analyses of protein extracts of carcinoma tissue from women with malignant breast disease. Protein
bands are stained with CB.
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Figure 3 A direct comparison of the CB-stained patterns of extracts from benign and malignant breast tissue that were separated
in pairs in three separate runs. The extra band in the malignant extracts is shown by a large arrow-head on the right of each pair.
These will subsequently be referred to as 'benign' and
'malignant' respectively. The data in these figures are
grouped according to the electrophoretic run in which a
specimen was separated. In Figure 2, pieces of the same
specimen ('u') were extracted on different occasions and
separated in different runs to illustrate the reproducibility of
the extraction and electrophoretic methods. In Figure 1, the
specimen from patient 'd' came from a lump that showed an
area of carcinoma, but the histopathology of the piece of
tissue adjacent to the piece used for protein extraction
showed no evidence of malignancy. The type of protein
pattern obtained for each group was very reproducible and
characteristic. Extracts from both groups have strong bands
at 68 Kd and 16 Kd; the 'benign' extracts usually having
higher levels of these components. From the molecular
weights of these two bands, one can be almost certain that
these components are albumin and haemoglobin.
Comparison of other parts of the CB-stained separations
indicate that the 'malignant' extracts express more bands
than the 'benign' extracts. Close examination, however,
indicates that many of these apparently extra bands are
present in the 'benign' extracts but at a much lower level.
This point is illustrated in Figure 3, where 'benign' and
'malignant' extracts are displayed, that were separated in
pairs in three runs. From detailed visual inspection and
scanning with a laser densitometer (data not shown), the
most consistent change observed between the two groups
was the appearance of an extra band at 58 Kd in the
'malignant' extracts (see Figures 2, 3). This band could not
be detected in any significant amount in the 'benign'
extracts.
The autoradiographs obtained after WGA treatment are
shown in Figures 4-6. The autoradiograph for a small area
at the top of the electrophoresis track is not shown because
it was impossible to interpret. For the majority of samples
there was a portion of intense WGA binding that extended
from the running gel up into the stacking gel and the bands
could not be resolved. The lectin binds to many components
of lower mol. wt in extracts from both groups. The patterns
are particularly consistent for 16/17 extracts in the 'benign'
group (see Figure 4). Comparison of the two groups indicate
that there are some very interesting differences. Up to three
bands in the 'benign' extracts appear to be either reduced or
absent in the 'malignant' extracts. These bands are in the
40-60Kd region and are labelled '1-3' on Figures 4 and 5.
Detailed inspection of the WGA patterns in the 'malignant'
group suggested that they could be further broken-down into
those extracts where at least two of the three bands were
expressed, albeit, sometimes at a reduced levels (sub-group
'A'), and those extracts where only one band was still visible
(sub-group 'B'). Examination of the histopathological
findings of tissue adjacent to the extracted material from the
'malignant' specimens indicated that sub-group 'B' (Figure 5)
contained 4/5 cases in which the margin infiltration was
observed. It should be emphasized, however, that infiltrative
tumour had been noted in all the specimens used for the
original diagnosis. This discrepancy is discussed later. Sub-
group 'B' also contained the cases (3/11) that were graded 3
by the Bloom & Richardson classification in the original
histopathology. There was no correlation between the WGA
pattern and tumour size or degree of fibrosis (data not
shown). The data for lymph node status was insufficient to
be used for analysis.
Figure 6 compares the CB and WGA patterns for three
particular patients; one patient is from the 'benign' group
and the two others from the 'malignant' group. Although
some of the bands on the two types of pattern appear to
match-up and could be the same component, it is clear that
the changes in glycosylation and protein composition do not
occur concurrently. For example, the 58Kd protein that is
expressed more strongly in the 'malignant' group has a
slightly lower mol. wt than the nearest WGA band (band 'I').
Similarly, WGA band '2' which disappears with increasing
malignancy corresponds to a protein band that increases.
Figure 7 illustrates the patterns obtained when blood
serum from three healthy individuals were electrophoretically252 R.C.Y. Ng et al.
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Figure 4 Autoradiographs of WGA-binding to separated extracts from benign breast tissue. Arrow-heads on the right indicate
thc position of the 3 bands that were reduced or lost in the malignant extracts (see Figure 5).
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Figure 5 Autoradiographs of WGA-binding to separated extracts from malignant breast tissue. The patients are organised into
two sub-groups that were selected on the basis of the degree of reduction in WGA-binding. In sub-group 'A', there are at least 2
of thc 3 bands visible, whereas in sub-group 'B' only one band is visible.
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Figure 6 A comparison of the CB-stained and WGA treated patterns for protein extracts from the breast tissue of a patient in
the benign group and of patients in the malignant sub-groups 'A' and 'B'.
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Figure 7 A comparison of the CB-stained and WGA-treated
electrophoretic patterns for sera from 3 healthy women. The
positions of the mol. wt markers are indicated by small arrows
on the left of the separations.
separated under the same conditions as those used for tissue
extracts. The CB-stained patterns are shown on the left of
the figure with the respective WGA-stained patterns on the
right. The patterns obtained for serum were much simpler
than those obtained for the tissue extracts with fewer bands
being detected. There are a number of bands, however, that
appear similar to those obtained for the tissue extracts,
particularly those on the CB-stained pattern of the 'benign'
group (compare Figures I & 7) and those on the WGA-
stained patterns in the 40-60 Kd region of the 'benign' group
(compare Figures 4 & 7).
Discussion
The current study has shown that consistent differences in
protein and glycoprotein composition can be detected in
extracts of biopsies taken from benign and malignant breast
tissue. The most striking of these being a reduction in the
expression of WGA-binding proteins related to the presence
of increasing malignancy. This finding is very similar to the
results we previously reported for animal metastatic tumour
systems (Chan et al., 1984; Chan et al., 1985). Changes in
WGA binding to human breast carcinoma cells in situ have
also been previously described (Walker, 1984). Using a
histochemical method it was shown that a loss in
differentiation of carcinoma cells was related to a decrease in
the number of cells reacting with WGA, and that there was
a significant correlation between decreased reactivity and the
presence of lymph node metastasis. Another study (Khan et
al., 1985), however, has reported that there was no difference
in the binding of WGA to breast carcinomas with or without
axillary lymph node involvement.
A protein with a molecular weight of 58 Kd was
consistently present in the cancer extracts and consistently
absent in the benign extracts. Estradiol stimulates the
synthesis of secretory proteins, ranging from 50-60 Kd, in
different human breast cancers cell lines (Capony et al.,
1982). Furthermore, one of these proteins, a 52 Kd molecule,
has been detected in the cytoplasm of epithelial mammary
cancer cells from 80% of primary breast cancers using a
monoclonal antibody; the same protein being undetectable in
normal mammary glands (Garcia et al., 1985). It is possible,
therefore, that these estrogen-regulated proteins and the
58 Kd protein we detected are related.
It could be argued that the changes we detected can be
explained by the contamination of tissue extracts by serum
proteins; this contamination being higher in the 'benign'
extracts than the 'malignant' extracts. Certainly some of the
bands in the 'benign' extract and the serum were of a similar
molecular weight. If this suggestion is true, then these
components must be strongly associated with the tissue
because the material used for the extractions was very finely
minced and extensively washed prior to treatment with
Triton XIOO (see Materials and methods). Furthermore, the
expression of these components in the 'benign' extracts was
very reproducible; this is not what one would expect if they
were due to soluble contaminating proteins. A previous
study has also reported substantial amounts of serum
contamination in minced breast tissue which cannot be
removed by washing (Irwin, 1981). Although the expression
of serum-like proteins in the 'malignant' extracts was very
variable and sometimes as high as in the 'benign' extracts, all
the cancer specimens showed the cancer associated changes.
Another explanation for some of the possible serum
protein contamination of the tissue extracts is that the breast
tissue is synthesizing these components. Gendler et al. (1982)
have shown that up to 30% of the radiolabelled proteins
synthesized by breast tissue are serum proteins. One of these
proteins was identified as cxl-acidglycoprotein (AGP). As this
protein has a molecular weight of 41 Kd and reacts strongly
with WGA in serum (see Figure 7), it is possible that WGA
band '3' in the extracts is also AGP. The reduced expression
of this component in 'malignant' tissue may represent either
reduced synthesis or an increased rate of loss. It is well
documented that serum AGP rises in cancer (Turner et al.,
1985).
From inspection of the WGA pattern for blood serum it
would seem possible that WGA band '1' for the tissue
extracts is also a serum component. The identity of this
component is more uncertain. From its mol. w (- 55 Kd) one
might speculate that it is Lxl-antitrypsin, another serum
glycoprotein that is raised in cancer (Turner et al., 1985). In
contrast to WGA bands '1' & '3', a band similar to band '2'
could not be seen in serum. Further studies are planned to
identify all these components more reliably using 2-
dimensional electrophoresis and immunoblotting.
The changes observed with WGA staining could also be
due to reduced or aberrant glycosylation of proteins.
Wilkinson et al., (1984) reported that the reduced expression
of an antigen, on a highly glycosylated molecule associated
with the human milk fat globule membrane, is related to
extremely poor prognosis and they interpreted this as being
due to a distorted pattern of processing of carbohydrate
side-chains. Also, Springer et al., (1976) have demonstrated
the appearance of the so called T antigen in breast cancers
and the expression of this is related to tumour spread. This
antigen is a precursor form of the blood group MN antigens
in which two sialic acid residues are missing from the
carbohydrate side-chain.
The importance of having local pathology for the
interpretation of biochemical data is emphasized by the
results in this study. Although all the tissue specimens used
for histological diagnosis showed signs of invasion, this
observation was reported in only 5/11 of the adjacent
specimens that were examined. Interestingly, the extent of
loss of WGA-binding correlated with the local pathology. A
similar type of discrepancy was found for patient 'd', who
was placed in the 'benign' group from the evidence of local
pathology; having been previously diagnosed as malignant.
Biochemically, this extract gave a benign protein pattern, but
a malignant glycoprotein pattern. This result suggests that254 R.C.Y. Ng et al.
WGA-binding may be a more sensitive and reliable indicator
of the presence of tumour than protein staining.
These results indicate intra-tumoral variability in the
expression of cellular proteins, however, no significant
variability was discovered within the samples of tissue that
were available for biochemistry in this study (all data not
shown, see 'u' Figure 2 for example). Intra-tumoral
variability may have been detected if all the diseased tissue
had been made available. Unfortunately, this was not the
case, and the requirements for diagnostic histopathology
obviously took precedence.
Several protein markers for human breast cancer have
been reported and many of these can be monitored in tissue
and body fluids by using monoclonal antibodies. The
changes in glycosylation that we have detected with WGA
suggest an alternative or additional approach to using these
immunological reagents. Monoclonal antibodies only
recognise molecules containing the epitope to which the
antibody was raised, whereas WGA will recognise a whole
host of different molecular species, provided that they
contain certain sugars. WGA, therefore, may have wider
application than monoclonal antibodies. Our results also
suggest that the degree of reduced glycosylation could be
correlated with the extent of tumour aggressiveness. Whether
this change has a role to play in the spreading process itself,
or is a by-product of it, is not known. Identifying the causes
of spread are very important for developing rational
programs of therapy. Further studies are necessary to
establish the nature and source of the abnormal
glycoproteins that we have detected in human breast cancer.
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